David Stamilio to Cost-Benefit Analysis
This is a "connection" page, showing publications David Stamilio has written about Cost-Benefit Analysis.
Connection Strength
0.770
-
Venkatesh KK, Clark LH, Stamilio DM. Cost-effectiveness of opportunistic salpingectomy vs tubal ligation at the time of cesarean delivery. Am J Obstet Gynecol. 2019 01; 220(1):106.e1-106.e10.
Score: 0.596
-
Kaimal AJ, Little SE, Odibo AO, Stamilio DM, Grobman WA, Long EF, Owens DK, Caughey AB. Cost-effectiveness of elective induction of labor at 41 weeks in nulliparous women. Am J Obstet Gynecol. 2011 Feb; 204(2):137.e1-9.
Score: 0.086
-
Cahill AG, Odibo AO, Caughey AB, Stamilio DM, Hassan SS, Macones GA, Romero R. Universal cervical length screening and treatment with vaginal progesterone to prevent preterm birth: a decision and economic analysis. Am J Obstet Gynecol. 2010 Jun; 202(6):548.e1-8.
Score: 0.021
-
Cahill AG, Odibo AO, Stamilio DM, Macones GA. Screening and treating for primary cytomegalovirus infection in pregnancy: where do we stand? A decision-analytic and economic analysis. Am J Obstet Gynecol. 2009 Nov; 201(5):466.e1-7.
Score: 0.020
-
Odibo AO, Stamilio DM, Macones GA, Polsky D. 17alpha-hydroxyprogesterone caproate for the prevention of preterm delivery: A cost-effectiveness analysis. Obstet Gynecol. 2006 Sep; 108(3 Pt 1):492-9.
Score: 0.016
-
Odibo AO, Coassolo KM, Stamilio DM, Ural SH, Macones GA. Should all pregnant diabetic women undergo a fetal echocardiography? A cost-effectiveness analysis comparing four screening strategies. Prenat Diagn. 2006 Jan; 26(1):39-44.
Score: 0.016
-
Odibo AO, Stamilio DM, Nelson DB, Sehdev HM, Macones GA. A cost-effectiveness analysis of prenatal screening strategies for Down syndrome. Obstet Gynecol. 2005 Sep; 106(3):562-8.
Score: 0.015